TALLAHASSEE, Fla., Jan. 29, 2026 /PRNewswire/ --Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that, further to its December 17, 2025 news release, it has closed a second tranche of its previously announced private placement of 10.5% Senior Secured Notes due 2030 (the "Notes") in the principal amount of US$60.0 million (the "Offering"). Together with the first offering of Notes, which closed on Dec ...

Core Viewpoint - Glass House Brands Inc. has appointed Alison Payne to its Board of Directors, effective January 27, 2026, to enhance its branding and marketing capabilities as it prepares for the rescheduling of cannabis [1][3]. Company Overview - Glass House Brands is recognized as one of the fastest-growing, vertically integrated cannabis companies in the U.S., focusing primarily on the California market [4]. - The company aims to build leading brands and offers a portfolio that includes Glass House Farms, PLUS Products, Allswell, and Mama Sue Wellness, along with a network of retail dispensaries [4]. Appointment Details - Alison Payne fills the vacant seat on the Board left by the passing of long-term member George Raveling in September 2025 [2]. - Payne has extensive international marketing experience, having held senior roles at Heineken, PepsiCo, Kellogg, and Diageo, and currently serves as the Chief Marketing Officer of Heineken, USA [3]. Strategic Importance - The appointment of Payne is seen as pivotal for Glass House as it prepares for potential growth and expansion opportunities, including geographic and product line diversification [3]. - Payne expressed her enthusiasm for joining the Board and contributing to the company's innovation and leadership in the cannabis market [4].

Vancouver, British Columbia--(Newsfile Corp. - January 28, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to report its financial results for the Fiscal Year (FY) 2025.For the twelve months ended September 30, 2025, the Company delivered a transformative performance, including a dramatic reduction in net loss, increased gross profit, and positive Adjusted EBITDA, ...

Core Insights - Curaleaf Holdings, Inc. will report its financial and operating results for Q4 and the full year ended December 31, 2025, on February 26, 2026, after market close [1] - The company is a leading international provider of consumer cannabis products, emphasizing quality, expertise, and reliability [3] Financial Reporting - The earnings conference call will take place on February 26, 2026, at 5:00 p.m. ET, featuring prepared remarks and a Q&A session [2] - A dial-in replay of the conference call will be available until March 5, 2026, for those unable to attend live [2] Company Overview - Curaleaf operates under various brands, including Curaleaf, Select, Grassroots, and others, providing a wide range of products in both medical and adult-use markets [3] - Curaleaf International is noted as the largest vertically integrated cannabis company in Europe, with a strong supply and distribution network [3]

I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the ...

Industry Overview - Cannabis stocks have experienced significant declines over the past few years due to factors such as legalization and intense competition, which have negatively impacted profit margins [1] Market Dynamics - The initial excitement surrounding cannabis legalization, referred to as the 'Green Rush,' has not translated into sustained financial success for many companies in the sector [1] Competitive Landscape - The fierce competition within the cannabis industry has contributed to the erosion of margins, making it challenging for companies to maintain profitability [1]

Core Viewpoint - Cannara Biotech Inc. has received conditional approval to uplist its common shares to the Toronto Stock Exchange from the TSX Venture Exchange, marking a significant milestone for the company [1][2]. Company Overview - Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products, operating two mega facilities in Québec that span over 1,600,000 square feet [1][4]. - The company has the potential annualized cultivation output of 100,000 kg, leveraging Québec's low electricity costs to produce affordable premium-grade cannabis products [4]. Uplisting Details - The final approval for the uplisting is contingent upon the company meeting specific conditions set by the TSX, after which its common shares will be delisted from the TSXV [3]. - Cannara's common shares will continue to trade under the stock symbol "LOVE" once listed on the TSX, with a press release to follow confirming the expected commencement date for trading [3]. Management Commentary - The CEO of Cannara expressed gratitude towards employees, shareholders, and partners for their support, emphasizing the uplisting as a validation of the company's vision and efforts [2]. - The management anticipates that the uplisting will enhance visibility to potential new investors and provide greater liquidity for shareholders as the company continues to execute its growth and profitability strategy [2].

Core Viewpoint - Scotts Miracle-Gro Company is in advanced discussions to sell its Hawthorne subsidiary to Vireo Growth, Inc., with the deal expected to close in the second quarter of fiscal 2026 [1] Group 1: Sale of Hawthorne Subsidiary - The proposed terms involve Vireo Growth acquiring Hawthorne in exchange for an investment in Vireo, integrating cultivation supply into its consumer cannabis operations [1] Group 2: Financial Reporting and Guidance - The company has classified the Hawthorne business as a discontinued operation effective in the first quarter of fiscal 2026 and reaffirmed its fiscal 2026 guidance [2] - In the first quarter, the net loss from continuing operations was $47.8 million, an improvement from a loss of $66.1 million in the prior year, with loss per share from continuing operations at $0.83 compared to $1.15 [3] - Adjusted net loss per common share from continuing operations was $0.77, down from $0.88 a year ago, while net sales were $354.4 million, reflecting a 3% decrease [3] Group 3: Share Repurchase Program - The Board has approved a share repurchase program authorizing the repurchase of up to $500 million of Scotts Miracle-Gro common stock [2] Group 4: Market Reaction - In pre-market trading on NYSE, Scotts Miracle-Gro shares decreased by 0.4 percent to $63.00 [4]

Core Viewpoint - Vireo Growth Inc. has entered into a nonbinding Memorandum of Understanding with The Scotts Miracle-Gro Company to acquire The Hawthorne Gardening Company LLC, a leading provider of indoor and hydroponic gardening materials in North America, with the transaction expected to be completed in the first fiscal quarter of 2026 [2][4]. Company Overview - Vireo Growth Inc. was founded in 2014 as a pioneering medical cannabis company, focusing on building a disciplined and execution-oriented platform in the industry [5]. - The company emphasizes a long-term mindset, a bias for action, and a commitment to its customers, employees, shareholders, and communities [5]. Transaction Details - The proposed acquisition aims to deepen the relationship between Vireo and ScottsMiracle-Gro, with Chris Hagedorn, Executive Vice President of ScottsMiracle-Gro, expected to join Vireo's Board of Directors upon completion [3][4]. - Jim Hagedorn, Chairman and CEO of ScottsMiracle-Gro, stated that the transition to an equity participation arrangement with Vireo aligns with their interests and allows them to focus on their core business [4].

Core Insights - The Canadian cannabis sector is evolving with companies adapting to changing consumer demands and global regulations, presenting long-term investment opportunities despite volatility [1][2] - U.S. federal reform is influencing sentiment among Canadian operators, with many maintaining indirect exposure to the U.S. market [1][3] Industry Overview - Companies are diversifying to stabilize revenue during downturns and focusing on cost control and operational efficiency to navigate tighter capital markets [2] - Strong balance sheets provide an advantage to resilient operators as weaker competitors retrench [2] - The sector is prioritizing profitability, cash preservation, and scalable growth over rapid expansion, making financial performance increasingly relevant [4] Company Strategies - **Tilray Brands, Inc. (TLRY)**: Diversified across cannabis, wellness, beverage alcohol, and consumer packaged goods, helping stabilize revenue during slowdowns. It has a strong international presence and indirect access to the U.S. market through hemp-derived products [5][6][10] - **Canopy Growth Corporation (CGC)**: Focused on adult-use and medical cannabis with a disciplined strategy. It has structured interests in U.S. THC and wellness businesses, positioning itself for regulatory changes while maintaining a strong retail presence in Canada [12][15][16] - **Village Farms International, Inc. (VFF)**: Combines cannabis and traditional agriculture, focusing on cultivation efficiency and wholesale distribution rather than dispensary ownership. It has shown significant revenue growth and strong cannabis margins [18][21][22] Financial Performance - Tilray has shown improving stability with record quarterly revenue, supported by beverage alcohol acquisitions and steady cannabis sales. It has moved into a net cash position, emphasizing cost controls and operational discipline [10][11] - Canopy Growth has made measurable progress with improving revenue trends and declining operating expenses, although profitability remains a challenge [16][17] - Village Farms has reported strong revenue growth and record cannabis margins, with positive cash flow supporting its balance sheet strength [21][22]